Prediagnostic plasma enterolactone levels and mortality among women with breast cancer
- 22 February 2011
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 128 (3), 883-889
- https://doi.org/10.1007/s10549-011-1397-2
Abstract
Experimental and epidemiological studies have suggested that the phytoestrogen enterolactone is associated to biological mechanisms that may have positive effects on breast cancer development. In a recent study based on American breast cancer patients, high intakes of lignans, the precursor of enterolactone, was found related to lower mortality. The aim of this study was, for the first time, to evaluate if prediagnostic plasma levels of enterolactone were associated to mortality in women diagnosed with breast cancer. Among 24,697 postmenopausal women included into a Danish cohort between 1993 and 1997, 424 developed breast cancer before December 31, 2000. Enterolactone levels were measured in baseline blood samples and related to mortality by Cox proportional hazard models. During a median of 10 years after breast cancer diagnosis, 111 women died (80 from breast cancer). When comparing women with enterolactone levels above the median (>20.5 nmol/l) to those with lower levels, decreased hazard rates (HR) were seen for both all-cause mortality (HR: 0.47; 95% confidence interval: 0.32–0.68) and breast cancer mortality (HR: 0.56; 95% confidence interval: 0.36–0.87). Higher prediagnostic plasma levels of enterolactone were found related to lower mortality among breast cancer patients.Keywords
This publication has 27 references indexed in Scilit:
- New hypotheses for the health-protective mechanisms of whole-grain cereals: what is beyond fibre?Nutrition Research Reviews, 2010
- Dietary lignan intakes in relation to survival among women with breast cancer: the Western New York Exposures and Breast Cancer (WEB) StudyBreast Cancer Research and Treatment, 2009
- Lifestyle changes and breast cancer prognosis: a reviewBreast Cancer Research and Treatment, 2008
- Flaxseed and its components reduce metastasis after surgical excision of solid human breast tumor in nude miceCancer Letters, 2006
- The inhibitory effect of flaxseed on the growth and metastasisof estrogen receptor negative human breast cancer xenograftsis attributed to both its lignan and oil componentsInternational Journal of Cancer, 2005
- Mammalian lignans and genistein decrease the activities of aromatase and 17β-hydroxysteroid dehydrogenase in MCF-7 cellsThe Journal of Steroid Biochemistry and Molecular Biology, 2005
- Dietary phytoestrogens and healthPhytochemistry, 2004
- The Role of Whole Grains in Disease PreventionJournal of the American Dietetic Association, 2001
- Rapid analysis of phytoestrogens in human urine by time-resolved fluoroimmunoassayThe Journal of Steroid Biochemistry and Molecular Biology, 2000
- Danish Breast Cancer Cooperative Group (DBCG) Structure and results of the organizationActa Oncologica, 1988